Triglyceride synthesis and VLDL metabolism pathway enzymes

The enzymes and proteins involved in triglyceride synthesis and very-low-density lipoprotein (VLDL) metabolism form a complex network responsible for the synthesis, storage, mobilization, and transport of triglycerides throughout the body. Key enzymes in triglyceride synthesis include glycerol-3-phosphate acyltransferase (GPAT), acylglycerol-3-phosphate acyltransferase (AGPAT), and diacylglycerol acyltransferase (DGAT), which catalyze consecutive steps in the formation of triglycerides predominantly in the liver and adipose tissue. In hepatocytes, triglycerides are packaged into VLDL particles with the help of apolipoprotein B-100 and microsomal triglyceride transfer protein (MTTP), then secreted into circulation. VLDL particles deliver triglycerides to peripheral tissues through the action of lipoprotein lipase (LPL), which hydrolyzes the triglyceride core, allowing release of free fatty acids for energy production or storage. Hepatic lipase further modifies VLDL remnants (IDL), which can be cleared by the liver or converted to low-density lipoprotein (LDL) for cholesterol transport. Regulatory proteins (e.g., apolipoproteins, CETP) and transcription factors (e.g., SREBP-1c, ChREBP, PPARα, LXR) tightly coordinate the pathway’s activity in response to dietary and hormonal cues. Disruption of these pathways contributes to metabolic and cardiovascular diseases[1][2][3][4][5][7]. Summary: This entity is not a specific, canonical molecular target but rather an umbrella term that includes a wide variety of proteins and enzymes. For structured databases or analyses, these should be parsed and entered as individual proteins (e.g., "Lipoprotein lipase", "Microsomal triglyceride transfer protein", "Diacylglycerol acyltransferase 1", etc.), rather than as a pathway or enzyme group[2][3][7].

Activation or inhibition of lipoprotein lipase or hepatic lipase Inhibition of triglyceride synthesis enzymes (e.g., DGAT inhibitors) Regulation of VLDL secretion Modulation of transcription factors involved in lipid metabolism